未登录.png)
分享.png)
收藏分享 收藏 分享 收藏 Geptanolimab in Chinese patients with relapsed or refractory primary mediastinal large B-cell lymphoma: Results from a multicenter, open-label, single-arm phase II trial
Shi, Y-K.; Cui, J.; Zhou, H.; Zhang, X.; Zou, L. Q.; Liu, H.; Zhang, H.; Li, X.; Zhang, W.; Zhou, F.; Zhong, L.; Jin, C.; Zhang, H.; Peng, Z.; Gao, Y.; Cao, J.; Ma, T. 分享 收藏 A randomized double-blind phase III study of niraparib versus placebo as maintenance therapy in extensive-stage small cell lung cancerAi, X.; Pan, Y.; Shi, J.; Yang, N.; Liu, C.; Zhou, J.; Zhang, X.; Dong, X.; He, J.; Li, X.; Chen, G.; Li, X.; Zhang, H.; Liao, W.; Zhang, Y.; Ma, Z.; Zhang, B.; Zhang, D.; Lu, S. 分享 收藏 Effect of anlotinib in advanced small cell lung cancer patients with pleural metastases/pleural effusion: A subgroup analysis from a randomized, double-blind phase II trial (ALTER1202)Liu, Y.; Cheng, Y.; Wang, Q.; Li, K.; Shi, J.; Wu, L.; Han, B.; Chen, G.; He, J.; Wang, J.; Qin, H.; Li, X. 分享 收藏 Effect of anlotinib in advanced small cell lung cancer (SCLC) patients with liver metastases: A subgroup analysis from a randomized, double-blind phase II trial (ALTER 1202)Cheng, Y.; Wang, Q.; Li, K.; Shi, J.; Wu, L.; Han, B.; Chen, G.; He, J.; Wang, J.; Qin, H.; Li, X. 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
